Close Menu

NEW YORK (GenomeWeb) – Roche has received the CE-IVD mark for a test to detect and distinguish Chlamydia trachomatis and Neisseria gonorrhoeae on its Cobas 6800/8800 Systems and has launched the test in countries that accept the CE marking.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.